
Canada has launched a clinical trial of an experimental Ebola vaccine developed at its national microbiology laboratory and expects to have the results in early 2015, the government said on Friday, Reuters reported.
The experimental vaccine, known as VSV-EBOV, was developed over several years at the laboratory in Winnipeg, Manitoba, and has shown promising results in animal research.
The trial will use a small group of volunteers in Halifax, Nova Scotia, and will complement other tests of the vaccine.
The vaccine is also being tested at the Walter Reed Army Institute of Research and National Institutes of Health, both in Maryland.
Canada has licensed the vaccine to a unit of Newlink Genetics Corp.
GMT 10:31 2018 Tuesday ,13 November
Russian police uproot 70 underground drug labs in past six monthsGMT 16:32 2018 Tuesday ,06 November
Rwanda aims to achieve universal access to clean water by 2024GMT 16:57 2018 Sunday ,04 November
Palestinian women witness higher cure rate of breast cancerGMT 13:11 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 10:44 2018 Tuesday ,23 October
Scientists find microplastics in human stool for first timeGMT 09:18 2018 Tuesday ,23 October
US judge upholds Monsanto weedkiller cancer verdict, reduces payoutGMT 14:22 2018 Friday ,19 October
Birth spacing ‘improving health of Omani women’GMT 15:40 2018 Monday ,15 October
Pakistani president launches nationwide anti-measles driveMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor